Table 2.
Recent applications of DSF.
| Test system | Study design | Study purpose, outcome | References |
|---|---|---|---|
|
Protein Therapeutics |
Tm determination for sets of protein variants or same protein across different buffer or formulation conditions |
Selection of best variant for further development, selection of storage conditions, improvement of formulations |
[19,30,43–46] |
| HTS | DSF-driven screens of small molecule libraries followed by orthogonal validation assays, e.g. DoT1L, monoglyceride lipase, HIV-1 NC, MLL/WDR5, FGF22 |
Discovery of novel ligands for select protein targets, accompanied recently by public deposition of large datasets |
[9,17,48,51,53] |
| Profiling | A set of small molecule ligands tested against a series of typically related proteins, e.g. kinases, PARPs |
Provides selectivity/promiscuity profiles of bioactive small molecules to understand off-target effects and improve development |
[8,52] |
|
Discovery of Chemical Chaperones |
Use of DSF to initially discover and/or to further characterize small molecule chaperones of mutant proteins in rare genetic diseases, e.g. correctors of ΔF508/CFTR, chaperones of glucocerebrosidase |
Discovery of novel ligands for select protein targets, particularly relevant in cases where noninhibitory protein stabilizers are desired |
[54,56,58] |
|
Stabilization by Cofactors or Other Proteins |
Profiling proteins for stabilization by protein binding partners and by combinations of cofactors and/or reaction substrates and products, e.g. PPI between E. coli MBP and Off730, Vibrio SDRvv cofactor, Ca2+ stabilization of vWF |
Provides insights into reaction mechanism, mechanisms of folding and stabilization of multidomain proteins, aids in the discovery of native cofactors of new proteins, ascertains formation of protein- protein complexes |
[36,60–62] |
|
Mechanism of Action of Inhibitors |
Cofactor and substrate co- dependency studies of protein stabilization to identify competitive- vs-noncompetitive modes, and to identify unusual modes of stabilization such as adduct formation, e.g. MOA of 15-PGDH inhibitors, PTC124-AMP adduct, GST MOA studies |
Provides initial insights into MOA, useful when the assay for the underlying enzymatic reaction is difficult to scale up for full enzyme kinetics study |
[63,65,68] |